{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T15:52:34Z","timestamp":1732031554079},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf00666065","type":"journal-article","created":{"date-parts":[[2004,11,27]],"date-time":"2004-11-27T13:43:07Z","timestamp":1101562987000},"page":"205-209","source":"Crossref","is-referenced-by-count":7,"title":["Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Sheldon","family":"Fine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Erlichman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Kaizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Warr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahany","family":"Gadalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.1988.6.10.1611","volume":"6","author":"JM Bennett","year":"1988","unstructured":"Bennett JM, Muss HB, Doroshow JH, Wolff S, Krement ET, Cartwright K, Dukart G, Reisman A, Schoch J: A randomized multicentre trial comparing Mitoxantrone, Cyclophosphamide and Fluorouracil in the therapy of metastatic breast carcinoma. J Clin Oncol 6: 1611?1620, 1988","journal-title":"J Clin Oncol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1200\/JCO.1988.6.9.1377","volume":"6","author":"IF Tannock","year":"1988","unstructured":"Tannock IF, Boyd NF, DeBoer G, Erlichman C, Fine S, Larocque G, Mayers C, Perrault D, Sutherland H: A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol 6: 1377?1387, 1988","journal-title":"J Clin Oncol"},{"key":"CR3","first-page":"247","volume-title":"Breast Cancer Diagnosis and Management","author":"IC Henderson","year":"1984","unstructured":"Henderson IC: Chemotherapy for advanced diasese. In: Bonadonna G (ed) Breast Cancer Diagnosis and Management. Wiley, New York, 1984, pp 247?280"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1200\/JCO.1988.6.3.469","volume":"6","author":"C Erlichman","year":"1988","unstructured":"Erlichman C, Fine S, Wong A, Elhakim T: A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 6: 469?475, 1988","journal-title":"J Clin Oncol"},{"key":"CR5","first-page":"655","volume":"8","author":"W Vliet Van der","year":"1989","unstructured":"Van der Vliet W, Erlichman C, Elhakim T: Allopurinol mouthwash for prevention of fluorouracil induced stomatitis. Clin Pharm 8: 655?658, 1989","journal-title":"Clin Pharm"},{"key":"CR6","first-page":"23","volume-title":"The Current Status of 5-Fluorouracil-Leucovorin Calcium Combination","author":"JA Houghton","year":"1984","unstructured":"Houghton JA, Houghton PJ: Basis for the interaction of 5-fluorouracil and leucovorin in colon adenocarcinoma. In: Bruckner HW, Rustum YM (eds) The Current Status of 5-Fluorouracil-Leucovorin Calcium Combination. Park Row, New York, 1984, pp 23?32"},{"key":"CR7","first-page":"3288","volume":"41","author":"RM Evans","year":"1981","unstructured":"Evans RM, Laskin JD, Hakala MT: Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res 41: 3288?329, 1981","journal-title":"Cancer Res"},{"key":"CR8","first-page":"190","volume":"2","author":"M-B Yin","year":"1982","unstructured":"Yin M-B, Zakrzewski SF, Hakala MT: Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil. Mol Pharmacol 2: 190?197, 1982","journal-title":"Mol Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1200\/JCO.1988.6.3.469","volume":"6","author":"C Erlichman","year":"1988","unstructured":"Erlichman C, Fine S, Wong A, Elhakim T: A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 6: 469?475, 1988","journal-title":"J Clin Oncol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1200\/JCO.1989.7.10.1407","volume":"7","author":"MA Poon","year":"1989","unstructured":"Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA: Biochemical modulation of 5-fluorouracil: Evidence of significant improvement in survival and quality of life in advanced colorectal carcinoma. J Clin Oncol 7: 1407?1418, 1989","journal-title":"J Clin Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.1989.7.10.1419","volume":"7","author":"N Petrelli","year":"1989","unstructured":"Petrelli N, Douglass HO, Herrera L, Russell D, Stablein DM, Bruckner HW, Mayer RJ, Schinella R: The modulation of Fluorouracil with Leucovorin in metastatic colorectal carcinoma: A prospective randomized phase III trial. J Clin Oncol 7: 1419?1426, 1989","journal-title":"J Clin Oncol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1200\/JCO.1989.7.4.439","volume":"7","author":"JH Doroshow","year":"1989","unstructured":"Doroshow JH, Leong L, Margolin K, Flanagan B, Goldberg D, Bertrand M, Akman S, Carr B, Odiyinrin D, Newman E, Litchfield T: Refractory metastatic breast cancer: Salvage therapy with fluorouracil and high dose continuous infusion leucovorin calcium. J Clin Oncol 7: 439?444, 1989","journal-title":"J Clin Oncol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1989.7.7.890","volume":"7","author":"SM Swain","year":"1989","unstructured":"Swain SM, Lippman ME, Egan EF, Drake JC, Steinberg SM, Allegra CJ: Fluorouracil and high-dose Leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 7: 890?899, 1989","journal-title":"J Clin Oncol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000226507","volume":"44","author":"G Marini","year":"1987","unstructured":"Marini G, Simoncini E, Zaniboni A, Gorni F, Marpicati P: 5-Fluorouracil and high-dose folinic acid as salvage treatment of advanced breast cancer: An update. Oncology 44: 336?340, 1987","journal-title":"Oncology"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00000421-198710000-00007","volume":"10","author":"P Pronzato","year":"1987","unstructured":"Pronzato P, Amoroso D, Ardizzoni A, Bertelli G, Canobbio L, Conte PF, Cusimano MP, Fusco V: Sequential administration of cyclosphosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancer. Am J Clin Oncol 10: 404?406, 1987","journal-title":"Am J Clin Oncol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1200\/JCO.1987.5.12.1928","volume":"5","author":"DL Ahmann","year":"1987","unstructured":"Ahmann DL, Schaid DJ, Bisel HF, Hahn RG, Edmonson JH, Ingle JN: The effect on survival of initial chemotherapy in advanced breast cancer: Poly-chemotherapy versus single drug. J Clin Oncol 5: 1928?1932, 1987","journal-title":"J Clin Oncol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1200\/JCO.1991.9.3.449","volume":"9","author":"DJ Mahood","year":"1991","unstructured":"Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM: Inhibition of Fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 9: 449?452, 1991","journal-title":"J Clin Oncol"},{"key":"CR18","first-page":"655","volume":"8","author":"W Vliet Van der","year":"1989","unstructured":"Van der Vliet W, Erlichman C, Elhakim T: Allopurinol mouthwash for prevention of fluorouracil-induced stomatitis. Clin Pharm 8: 655?658, 1989","journal-title":"Clin Pharm"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/1097-0142(19900415)65:8<1879::AID-CNCR2820650834>3.0.CO;2-8","volume":"65","author":"CL Loprinzi","year":"1990","unstructured":"Loprinzi CL, Cianflone SG, Dose AM, Etzell PS, Burnham NL, Therneau TM, Hagen L, Gainey DK, Cross M, Athmann LM, Fischer T, O'Connell MJ: A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-Fluorouracil induced stomatitis. Cancer 65: 1879?1882, 1990","journal-title":"Cancer"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.1991.9.2.305","volume":"9","author":"French Epirubicin Study Group","year":"1991","unstructured":"French Epirubicin Study Group. A prospective randomized trial comparing Epirubicin monochemotherapy to two Fluorouracil, Cyclosphosphamide, and Epirubicin regimens differing in Epirubicin dose in advanced breast cancer patients. J Clin Oncol 9: 305?312, 1991","journal-title":"J Clin Oncol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1200\/JCO.1991.9.12.2148","volume":"9","author":"DJ Perez","year":"1991","unstructured":"Perez DJ, Harvey VJ, Robinson BA, Atkinson CH, Dady PJ, Kirk AR, Evans BD, Chapman PJ: A randomized comparison of single-agent Doxorubicin and Epirubicin dose in advanced breast cancer patients. J Clin Oncol 9: 2148?2152, 1991","journal-title":"J Clin Oncol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/07357909109039875","volume":"9","author":"RM Hansen","year":"1991","unstructured":"Hansen RM: 5-Fluorouracil by protracted venous infusion: a review of recent clinical studies. Cancer Investigation 9: 637?642, 1991","journal-title":"Cancer Investigation"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/1097-0142(19890315)63:6+<1045::AID-CNCR2820631310>3.0.CO;2-B","volume":"63","author":"CL Loprinzi","year":"1989","unstructured":"Loprinzi CL: 5-Fluorouracil with leucovorin in breast cancer. Cancer 63: 1045?1047, 1989","journal-title":"Cancer"},{"key":"CR24","first-page":"97","volume-title":"Leucovorin Modulation of Fluoropyrimidines: a New Frontier in Cancer Chemotherapy","author":"A Zaniboni","year":"1989","unstructured":"Zaniboni A, Marini G: 5-Fluorouracil and high-dose leucovorin in advanced breast cancer: Personal experience. In: Pinedo HM, Rustum YM (eds) Leucovorin Modulation of Fluoropyrimidines: a New Frontier in Cancer Chemotherapy. Royal Society of Medicine Services, New York, 1989, pp 97?106"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0277-5379(89)90408-2","volume":"25","author":"A Zaniboni","year":"1989","unstructured":"Zaniboni A, Simoncini E, Marpicati P, Montini E, Ferrari V, Ferragni A, Boari L, Marini G: Cyclophosphamide, Epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) of first-line chemotherapy for advanced breast cancer: Preliminary results. Eur J Cancer Clin Oncol 25: 1151?1155, 1989","journal-title":"Eur J Cancer Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00666065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00666065\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00666065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T07:33:30Z","timestamp":1554449610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00666065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF00666065"],"URL":"https:\/\/doi.org\/10.1007\/bf00666065","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}